ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Minimizing Hurdles For Patients During The eConsent Process

  Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.

• Enhancing The Accessibility And Affordability Of Healthcare

  The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.

• The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials

  Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

• 2024 MedTech Regulatory Updates: 4 Areas Of Interest

  In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.

• How Technology Can Empower CAR T-Cell Therapy Clinical Trials

  Explore how innovative technologies are pushing advancements in CAR T-cell therapy, enhancing patient outcomes, and streamlining trial processes.

• Mental Health Apps: Regulation And Validation Are Needed

  Explore a proposed digital ecosystem that would balance rigorous validation with the urgent need for accessible mental health solutions, transforming the landscape into a resource for global well-being.

• Reduce Workloads And Improve Insights With Crowdsource UAT

  Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.

• Demystifying AI: The Fundamentals And Applications In Drug Development

  Explore the history of AI, gain clarity on key concepts, address common questions, and discover its transformative role in drug development, with insights into its current and future impact on the industry.

• Strengthening eClinical Data Integrity: Data Monitoring

  As the use of eCOA expands to incorporate more submission-critical elements, especially key endpoints and factors contributing to protocol analyses, learn how customized compliance strategies are more important than ever to ensure data integrity.

• Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study

  Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.